{"id":"NCT01214850","sponsor":"Novartis Vaccines","briefTitle":"Novartis Vaccine and Diagnostics Carriage Trial","officialTitle":"A Phase 3 Observer Blind Randomized, Multi-center, Controlled Study to Evaluate the Effect of Novartis Vaccine's Meningococcal B Recombinant and MenACWY Conjugate Vaccines on Pharyngeal Carriage of N. Meningitidis in Young Adults","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-09","primaryCompletion":"2012-01","completion":"2012-01","firstPosted":"2010-10-05","resultsPosted":"2014-01-23","lastUpdate":"2016-04-21"},"enrollment":2968,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"PREVENTION"},"conditions":["N. Meningitidis Carriage"],"interventions":[{"type":"BIOLOGICAL","name":"Meningococcal B Recombinant + Outer Membrane Vesicle vaccine (rMenB+OMV NZ)","otherNames":[]},{"type":"BIOLOGICAL","name":"MenACWY-CRM conjugate vaccine","otherNames":[]},{"type":"BIOLOGICAL","name":"Japanese Encephalitis vaccine","otherNames":["IXIARO"]}],"arms":[{"label":"rMenB+OMV","type":"EXPERIMENTAL"},{"label":"MenACWY","type":"EXPERIMENTAL"},{"label":"Control","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this trial was to evaluate the effect of Novartis Vaccine's Meningococcal vaccines on carriage of Neisseria meningitidis in a young adult population.","primaryOutcome":{"measure":"Percentages of Subjects With Carriage of Virulent Sequence Types (ST) of Neisseria Meningitidis Group B, One Month After Completion of rMenB+OMV NZ Vaccination","timeFrame":"61 days (31 days after receiving the second injection)","effectByArm":[{"arm":"rMenB+OMV","deltaMin":8,"sd":null},{"arm":"Control","deltaMin":7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.3828"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":14},"locations":{"siteCount":10,"countries":["United Kingdom"]},"refs":{"pmids":["25247300","25145775"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":31,"n":974},"commonTop":["Injection site pain","Myalgia","Injection site erythema","Headache","Malaise"]}}